For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Minimally Invasive Lumbar Decompression (MILD) | Image guided minimally-invasive lumbar decompression Minimally Invasive Lumbar Decompression: The percutaneous procedure is performed under fluoroscopic guidance to effect a lumbar decompression with minimal surrounding tissue and bone disruption. The mildĀ® Device Kit is utilized to access, capture and remove bone and tissue. | 2 | None | 18 | 149 | 2 | 149 | View |
| Epidural Steroid Injection (ESI) | An epidural steroid injection (ESI) is a combination of a corticosteroid with a local anesthetic pain relief medicine. Epidural Steroid Injection: Injection of epidural steroids into the lumbar spine | 0 | None | 13 | 153 | 2 | 153 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Respiratory, thoracic and mediastinal disorders | None | Respiratory, thoracic and mediastinal disorders | MedDRA (18.0) | View |
| Surgical and medical procedures | None | Surgical and medical procedures | MedDRA (18.0) | View |
| Cardiac Disorders | None | Cardiac disorders | MedDRA (18.0) | View |
| Gastrointestinal Disorders | None | Gastrointestinal disorders | MedDRA (18.0) | View |
| General disorders and administration site conditions | None | General disorders | MedDRA (18.0) | View |
| Infections and infestations | None | Infections and infestations | MedDRA (18.0) | View |
| Injury, poisoning and procedural complications | None | Injury, poisoning and procedural complications | MedDRA (18.0) | View |
| Musculoskeletal and connective tissue disorders | None | Musculoskeletal and connective tissue disorders | MedDRA (18.0) | View |
| Neoplasms benign, malignant and unspecifie | None | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA (18.0) | View |
| Nervous system disorders | None | Nervous system disorders | MedDRA (18.0) | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Injury, poisoning and procedural complications | None | Injury, poisoning and procedural complications | MedDRA (18.0) | View |
| Cardiac disorders | None | Cardiac disorders | MedDRA (18.0) | View |
| Musculoskeletal and connective tissue disorders | None | Musculoskeletal and connective tissue disorders | MedDRA (18.0) | View |